Walgreens Boots Alliance (BUE:WBA) Stock Based Compensation: ARS144,797.61 Mil (TTM As of May. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Walgreens Boots Alliance Stock Based Compensation?

Walgreens Boots Alliance BUE:WBA 15 Stock Based Compensation is ARS144,797.61 Mil as of May. 2025. GuruFocus rates BUE:WBA with a GF Score™ of 15/100. The stock has 7 warning signs investors should review.

Walgreens Boots Alliance's Stock Based Compensation for the three months ended in May. 2025 was ARS48,528.16 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in May. 2025 was ARS144,797.61 Mil.

Walgreens Boots Alliance Stock Based Compensation Related Terms

Walgreens Boots Alliance Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Walgreens Boots Alliance's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Walgreens Boots Alliance Stock Based Compensation Chart

Walgreens Boots Alliance Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9,906.47 11,208.05 51,568.99 106,260.00 169,624.00

Walgreens Boots Alliance Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38,566.00 36,348.00 37,620.00 22,301.45 48,528.16

Walgreens Boots Alliance Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in May. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ARS144,797.61 Mil.

What does a Stock Based Compensation of ARS144,797.61 Mil mean?
Walgreens Boots Alliance (BUE:WBA) has a Stock Based Compensation of ARS144,797.61 Mil as of May. 2025. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Walgreens Boots Alliance and its competitors.
Is Walgreens Boots Alliance's Stock Based Compensation too high?
Walgreens Boots Alliance's current Stock Based Compensation is ARS144,797.61 Mil. Overall, Walgreens Boots Alliance has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Walgreens Boots Alliance's Stock Based Compensation compare to WGRX and PETS?
Walgreens Boots Alliance's Stock Based Compensation of ARS144,797.61 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Walgreens Boots Alliance and its competitors. Walgreens Boots Alliance's current Stock Based Compensation is ARS144,797.61 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Walgreens Boots Alliance stock overvalued right now?
Walgreens Boots Alliance (BUE:WBA) has a current Stock Based Compensation of ARS144,797.61 Mil. The current Stock Based Compensation is ARS144,797.61 Mil. Walgreens Boots Alliance's overall GF Score™ is 15/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Walgreens Boots Alliance (BUE:WBA), the current Stock Based Compensation is ARS144,797.61 Mil as of May. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Walgreens Boots Alliance Business Description

Address 108 Wilmot Road, Deerfield, IL, USA, 60015
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.